DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Singleton JW, Hanauer SB, Gitnick GL. et al. and the Pentasa Crohn’s Disease Study Group.
Mesalamine capsules for the treatment of active Crohn’s disease: Results of a 16-week trial.
Gastroenterology 1993; 104: 1293-1301
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.